
Higher sales in its Life Sciences business helped GE Healthcare achieve slightly higher revenues for the fiscal fourth quarter of 2019 and the year.
For all of 2019 (end-December 31, 2019), revenues increased 1% to $19.942 billion, compared with $19.784 billion in 2018. Total orders also advanced 1% to $21.172 billion in 2019, compared with $20.897 billion in 2018. GE Healthcare's profit gained 5% to $3.896 billion last year, compared with $3.698 billion 2018.
The company reported that sales in the quarter for its Life Sciences business were up 2%, while the Healthcare Systems division was down 1%. Orders for the period were driven by growth in GE's Life Care Solutions, Services, and Ultrasound divisions; this growth was partially offset by GE's Imaging business.
In the fourth quarter of 2019, revenues climbed slightly to $5.402 billion, compared with $5.398 in the fourth quarter of 2018. Orders rose 2% to $5.896 billion in the quarter, compared with $5.756 billion in the same quarter of 2018. In addition, profit was up 2% to $1.183 billion, compared with $1.176 billion in 2018's fourth quarter.


















![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)
